#oncology #Novartis #MHRA #MHRAauthorisation #ribociclib #Breastcancer #Breastcancertherapy #aromataseinhibitor #advancedbreastcancer #MHRAdecision #phaseIIIclinicaltrial #NATALEEclinicaltrial l #overallsurvival #patientoutcomes #NICE #SMC #NHSreimbursement
pharmatimes.com/news/novarti...
0
0
0
0